The Efficacy and Safety of Caffeic Acid for Esophageal Cancer

NCT03070262 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Esophagus Cancer

Interventions

DRUG: CA
DRUG: placebo group

Sponsor

The First Affiliated Hospital of Henan University of Science and Technology

Collaborators

[object Object]
[object Object]